Isabelle Lascombe

Summary

Country: France

Publications

  1. ncbi request reprint Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors
    Anne Clairotte
    Department of Pathologic Cytology and Anatomy, Jean Minjoz University Hospital, Besancon, France
    Am J Clin Pathol 125:119-26. 2006
  2. ncbi request reprint N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors
    Isabelle Lascombe
    Tissue and Cell Biology Engineering, Besancon, France
    Clin Cancer Res 12:2780-7. 2006
  3. pmc The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL
    Marie Laure Plissonnier
    Laboratoire de Biologie Cellulaire et Moleculaire, Faculté des Sciences Médicales et Pharmaceutiques, Equipe d Accueil 3181 Institut Fédératif de Recherche N 133, Universite de Franche Comte, Besancon, France
    PLoS ONE 6:e28354. 2011
  4. ncbi request reprint The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism
    Nicolas Clere
    EA 3181 IFR N 133, Universite de Franche Comte, and Laboratoire de Biochimie Médicale, Centre Hospitalier Universitaire, Besancon, France
    Exp Cell Res 313:3239-50. 2007
  5. doi request reprint Insights on distinct pathways of thiazolidinediones (PPARgamma ligand)-promoted apoptosis in TRAIL-sensitive or -resistant malignant urothelial cells
    Marie Laure Plissonnier
    Laboratoire de Biologie Cellulaire et Moleculaire, EA3181 IFR N133, Universite de Franche Comte, UFR des Sciences Médicales et Pharmaceutiques, Besancon, France
    Int J Cancer 127:1769-84. 2010
  6. ncbi request reprint Differential regulation of vascular endothelial growth factor expression by peroxisome proliferator-activated receptors in bladder cancer cells
    Sylvie Fauconnet
    Institut d Etudes et de Transfert de Gènes Bâtiment INSERM, 240 route de Dole, Besancon, France
    J Biol Chem 277:23534-43. 2002

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Expression of E-cadherin and alpha-, beta-, gamma-catenins in patients with bladder cancer: identification of gamma-catenin as a new prognostic marker of neoplastic progression in T1 superficial urothelial tumors
    Anne Clairotte
    Department of Pathologic Cytology and Anatomy, Jean Minjoz University Hospital, Besancon, France
    Am J Clin Pathol 125:119-26. 2006
    ..The characterization of T1 tumors that will progress could lead to the identification of patients who might benefit from surgery to avoid vesical muscle invasion and, consequently, metastasis...
  2. ncbi request reprint N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors
    Isabelle Lascombe
    Tissue and Cell Biology Engineering, Besancon, France
    Clin Cancer Res 12:2780-7. 2006
    ..The purpose of this study was to investigate whether N-cadherin expression was associated with the bladder tumor progression...
  3. pmc The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL
    Marie Laure Plissonnier
    Laboratoire de Biologie Cellulaire et Moleculaire, Faculté des Sciences Médicales et Pharmaceutiques, Equipe d Accueil 3181 Institut Fédératif de Recherche N 133, Universite de Franche Comte, Besancon, France
    PLoS ONE 6:e28354. 2011
    ..Apart from its antidiabetic activity, this molecule shows antineoplastic effectiveness in numerous cancer cell lines...
  4. ncbi request reprint The human papillomavirus type 18 E6 oncoprotein induces Vascular Endothelial Growth Factor 121 (VEGF121) transcription from the promoter through a p53-independent mechanism
    Nicolas Clere
    EA 3181 IFR N 133, Universite de Franche Comte, and Laboratoire de Biochimie Médicale, Centre Hospitalier Universitaire, Besancon, France
    Exp Cell Res 313:3239-50. 2007
    ..Collectively, these results suggest that HPV18 E6 oncoprotein contributes to tumor angiogenesis by inducing VEGF transcription from the promoter in a p53-independent manner...
  5. doi request reprint Insights on distinct pathways of thiazolidinediones (PPARgamma ligand)-promoted apoptosis in TRAIL-sensitive or -resistant malignant urothelial cells
    Marie Laure Plissonnier
    Laboratoire de Biologie Cellulaire et Moleculaire, EA3181 IFR N133, Universite de Franche Comte, UFR des Sciences Médicales et Pharmaceutiques, Besancon, France
    Int J Cancer 127:1769-84. 2010
    ..Therefore, the combination of rosiglitazone and TRAIL could be clinically relevant as chemopreventive or therapeutic agents for the treatment of TRAIL-resistant high-grade urothelial cancers...
  6. ncbi request reprint Differential regulation of vascular endothelial growth factor expression by peroxisome proliferator-activated receptors in bladder cancer cells
    Sylvie Fauconnet
    Institut d Etudes et de Transfert de Gènes Bâtiment INSERM, 240 route de Dole, Besancon, France
    J Biol Chem 277:23534-43. 2002
    ..They may lead to a new therapeutic approach to human bladder cancer in which excessive angiogenesis is a negative prognostic factor...